Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Marcus O. Butler et al.|New England Journal of Medicine|2021Cited by 869
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEsSimon Eschweiler, Christian H. Ottensmeier, Ciro Ramírez-Suástegui et al.|Nature|2022Cited by 91